Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students

Infection and Immunity

Volumn 72, Issue 11, 2004, Pages 6503-6510

  Jordens, J Zoe ^a,b,d   Williams, Jeannette N ^a   Jones, Graeme R ^a,b   Christodoulides, Myron ^a   Heckels, John E ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CARRIER; BACTERIUM DETECTION; BLOOD GROUP TYPING; COHORT ANALYSIS; COLLEGE STUDENT; CROSS REACTION; DISEASE TRANSMISSION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNITY; LONGITUDINAL STUDY; MENINGITIS; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; SEPTICEMIA; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; CARRIER STATE; COHORT STUDIES; HUMANS; LONGITUDINAL STUDIES; MENINGOCOCCAL INFECTIONS; NASOPHARYNX; NEISSERIA MENINGITIDIS, SEROGROUP B; STUDENTS; UNIVERSITIES;

EID: 7044235512     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.11.6503-6510.2004     Document Type: Article

References (38)

1. Ala'Aldeen, D. A., K. R. Neal, K. Ait-Tahar, J. S. Nguyen-van-Tam, A. English, T. J. Falla, P. M. Hawkey, and R. C. Slack. 2000. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J. Clin. Microbiol. 38:2311-2316.
2. Balmer, P., R. Borrow, and E. Miller. 2002. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 51:717-722.
3. Brooks, J. L., R. J. Fallon, and J. E. Heckels. 1995. Sequence variation in class 1 outer membrane protein in Neisseria meningitidis isolated from patients with meningococcal infection and close household contacts. FEMS Microbiol. Lett. 128:145-150.
4. Cartwright, K. A. V. 1995. Meningococcal carriage and disease, p. 115-146. In K. A. V. Cartwright (ed.) Meningococcal disease. John Wiley & Sons, Chichester, United Kingdom.
5. Corless, C. E., M. Guiver, R. Borrow, V. Edwards-Jones, A. J. Fox, and E. B. Kaczmarski. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J. Clin. Microbiol. 39:1553-1558.
6. Fernandez, S., I. Arreaza, I. Santiago, A. Malvar, S. Berron, J. A. Vazquez, and X. Hervada. 2003. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. J. Med. Microbiol. 52:75-77.
7. Gilmore, A., G. Jones, M. Barker, N. Soltanpoor, and J. M. Stuart. 1999. Meningococcal disease at the University of Southampton: outbreak investigation. Epidemiol. Infect. 123:185-192.
8. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
9. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
10. Greenfield, S., and H. A. Feldman. 1967. Familial carriers and meningococcal meningitis. N. Engl. J. Med. 277:497-502.
11. Greenfield, S., P. R. Sheehe, and H. A. Feldman. 1971. Meningococcal carriage in a population of normal families. J. Infect. Dis. 123:67-73.
12. Greenwood, B. M., M. Hassan-King, and H. C. Whittle. 2003. Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Br. Med. J. 1:1317-1319.
13. Guiver, M., R. Borrow, J. Marsh, S. J. Gray, E. B. Kaczmarski, D. Howells, P. Boseley, and A. J. Fox. 2000. Evaluation of the Applied Biosystems automated TaqMan polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol. Med. Microbiol. 28:173-179.
14. Guttormsen, H. K., L. M. Wetzler, and C. O. Solberg. 1994. Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect. Immun. 62:1437-1443.
15. Jones, G. R., M. Christodoulides, J. L. Brooks, A. R. O. Miller, K. A. V. Cartwright, and J. E. Heckels. 1998. Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonisation. J. Infect. Dis. 178:451-459.
16. Jones, G. R., J. N. Williams, M. Christodoulides, K. Jolley, and J. E. Heckels. 2000. Lack of immunity in university students prior to an outbreak of serogroup C meningococcal infection. J. Infect. Dis. 181:1172-1175.
17. Jordens, J. Z., J. N. Williams, G. R. Jones, and J. E. Heckels. 2002. Detection of meningococcal carriage by culture and PCR of throat swabs and mouth gargles. J. Clin. Microbiol. 40:75-79.
18. Kristiansen, B. E., Y. Treten, and A. Jenkins. 1998. Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study. Br. Med. J. 317:621-625.
19. Kvalsvig, A. J., and D. J. Unsworth. 2002. The immunopathogenesis of meningococcal disease. J. Clin. Pathol. 56:417-422.
20. Mandrell, R. E., and W. D. Zollinger. 1989. Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect. Immun. 57:1590-1598.
21. McGuinness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1991. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337:514-517.
22. Milagres, L. G., M. C. Gorla, C. T. Sacchi, and M. A. Rodrigues. 1998. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect. Immun. 66:4755-4761.
23. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. A. Melles, V. S. D. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
24. Peltola, H. 1983. Meningococcal disease: still with us. Rev. Infect. Dis. 5:71-91.
25. Quakyi, E. K., C. E. Frasch, N. Buller, and T. Chao-Ming. 1999. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental Group B Neisseria meningitidis infection and septic shock. J. Infect. Dis. 180:747-754.
26. Ramsay, M. E., N. J. Andrews, C. L. Trotter, E. B. Kaczmarski, and E. Miller. 2003. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Br. Med. J. 326:365-366.
27. Robinson, K., K. R. Neal, C. Howard, J. Stockton, K. Atkinson, E. Scarth, J. Moran, A. Robins, I. Todd, E. Kaczmarski, S. Gray, I. Muscat, R. Slack, and D. A. A. Ala'aldeen. 2002. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect. Immun. 70:1301-1309.
28. Rosenqvist, E., E. A. Hoiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Ronnild, G. Bjune, and H. Nokleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
29. Rouppe van der Voort, E. M., M. Schuller, J. Holst, P. de Vries, P. van der Ley, G. van den Dobbelsteen, and J. Poolman. 2000. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys. Vaccine 18:1334-1343.
30. Rouppe van der Voort, E. M., H. van Dyken, B. Kuipers, J. van der Biezen, P. van der Ley, J. Meylis, I. Claassen, and J. Poolman. 1998. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine. Infect. Immun. 65:5184-5190.
31. Scholten, R. J. P. M., B. Kuipers, H. A. Valkenhurg, J. Dankert, W. D. Zollinger, and J. T. Poolman. 1994. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J. Med. Microbiol. 41:236-243.
32. Stephens, D. S. 1999. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 353:941-942.
33. Tappero, J. W., R. Reporter, J. D. Wenger, B. A. Ward, M. W. Reeves, T. S. Missbach, B. D. Plikaytis, L. Mascola, and A. Schuchat. 1996. Meningococcal disease in Los Angeles County, California, and among men in the county jails. N. Engl. J. Med. 335:833-840.
34. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
35. Vermont, C., and G. van den Dohhelsteen. 2002. Neisseria meningitidis serogroup B: laboratory correlates of protection. FEMS Immunol. Med. Microbiol. 34:89-96.
36. Wedege, E., E. A. Hoiby, E. Rosenqvist, and G. Bjune. 1998. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect. Immun. 66:3223-3231.
37. Williams, J. N., G. R. Jones, M. Christodoulides, and J. E, Heckels. 2003. Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection. J. Infect. Dis. 187:1433-1441.
38. Zollinger, W. D., and R. E. Mandrell. 1983. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect. Immun. 40:257-264.